Hans Jürgen Hoffmann

Professor

Aarhus Universitet Health

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hans Jürgen Hoffmann is a Professor at Aarhus Universitet Health in Denmark. His research areas include the classification of type 2 asthma, management tools for allergic asthma, and intralymphatic immunotherapy. He has published recent articles examining biomarkers for asthma and drug hypersensitivity, as well as the health effects of indoor ultrafine particles. Prof. Hoffmann’s work contributes to advancements in asthma treatment and allergy management.

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (9)

Lene H. Garvey

DENMARK

View details

Claudia Lang

University Hospital of Zurich

SWITZERLAND

View details

Sune Rubak

Aarhus University

DENMARK

View details

Boe Sorensen

Aarhus University

DENMARK

View details

Annick BARBAUD

FRANCE

View details

Johannes Schmid

Aarhus University

DENMARK

View details

Alexandra Santos

Clinical Professor of Paediatric Allergy

King’s College London

UNITED KINGDOM

View details

Andreas Bonertz

Head of Section

Paul-Ehrlich-Institut

GERMANY

View details

Jonas Erjefält

Professor

Lund University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hans Jürgen Hoffmann

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

How to hit the allergy target

A five-gene qPCR signature can classify type 2 asthma comparably to microscopy of induced sputum from severe asthma patients

Flow‐based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paper

Basophil FceRI expression—A management tool in anti‐IgE treatment of allergic asthma

Ultrasound‐guided intralymphatic immunotherapy: A single‐center trial of a clinical skills training programme

Ultrasound-guided intralymphatic immunotherapy: A single-center trial of a clinical skills training programme

Airway and systemic biomarkers of health effects after short-term exposure to indoor ultrafine particles from cooking and candles - A randomized controlled double-blind crossover study among mild asthmatic subjects

Glial fibrillary acidic protein is a robust biomarker in cerebrospinal fluid and peripheral blood after traumatic spinal cord injury: a prospective pilot study

Sputum eosinophilia is a useful biomarker for treatment failure of biologics for severe eosinophilic asthma

Strengthening the case for intralymphatic immunotherapy

Basophil sensitivity reflects long‐term clinical outcome of subcutaneous immunotherapy in grass pollen‐allergic patients

Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice

The number of successful injections associates with improved clinical effect in intralymphatic immunotherapy

In‐vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan—An EAACI position paper

Collaborators (9)

Lene H. Garvey

Claudia Lang

Sune Rubak

Boe Sorensen

Annick BARBAUD

Johannes Schmid

Alexandra Santos

Andreas Bonertz

Jonas Erjefält

Make your next move.